DBV Technologies SA
(NAS:DBVT)
$
3.9
0.835 (27.24%)
Market Cap: 68.07 Mil
Enterprise Value: 29.75 Mil
PE Ratio: 0
PB Ratio: 1.32
GF Score: 39/100 DBV Technologies SA at Barclays Global Healthcare Conference Transcript
Mar 13, 2019 / 02:45PM GMT
Release Date Price:
$86.3
(+1.29%)
Geoffrey Christopher Meacham
Barclays Bank PLC, Research Division - MD & Senior Research Analyst
(technical difficulty) I'm the senior biopharma analyst here at the firm. I have Scott Puckhaber from my team on stage with me as well. So we're excited to have DBV Technologies here on stage for a fireside chat. Its Chief Commercial Officer, Kevin Trapp; and Chief Business Officer Susanna Mesa.
Susanna Mesa
DBV Technologies S.A. - Chief Business Officer
Thank you.
Kevin Trapp
DBV Technologies S.A. - Chief Commercial Officer
Hey Geoff, Thanks for having us.
Geoffrey Christopher Meacham;Kevin Trapp
Barclays Bank PLC, Research Division - MD & Senior Research Analyst;DBV Technologies
Welcome guys. Yes, of course. So we've got a lot of questions here, but maybe just if you want to kick it off for maybe some of the audience that aren't as familiar just a kind of a 2 minute, kind of, background, and then we will get right in the question.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot